Patents by Inventor Martin Andreas Folger

Martin Andreas Folger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING PERGOLIDE
    Publication number: 20190374534
    Abstract: The invention relates to novel liquid pharmaceutical compositions comprising (8?)-8-[(methylthio)methyl]-6-propylergoline (pergolide) as well as corresponding processes of manufacturing such liquid pharmaceutical compositions and their medical uses.
    Type: Application
    Filed: June 5, 2019
    Publication date: December 12, 2019
    Inventors: Martin Andreas FOLGER, Monika BRINK, Marcus Rainer RAHMEL
  • Water-soluble meloxicam granules
    Patent number: 8992980
    Abstract: Water soluble meloxicam granules comprising: (a) meloxicam; (b) a salt forming agent which forms the meglumine, sodium, potassium, or ammonium salt of meloxicam; (c) a binder; (d) a sugar or sweetener; and (e) a carrier, and optionally a flavoring agent and optionally other excipients, processes for preparing them and their use for treating respiratory or inflammatory complaints in mammals.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: March 31, 2015
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Martin Andreas Folger, Jens Schmalz, Diana Christine Keilhofer, Hans-Juergen Kroff, Nina Herz
  • Water-Soluble Meloxicam Granules
    Publication number: 20130005714
    Abstract: Water soluble meloxicam granules comprising: (a) meloxicam; (b) a salt forming agent which forms the meglumine, sodium, potassium, or ammonium salt of meloxicam; (c) a binder; (d) a sugar or sweetener; and (e) a carrier, and optionally a flavoring agent and optionally other excipients, processes for preparing them and their use for treating respiratory or inflammatory complaints in mammals.
    Type: Application
    Filed: September 5, 2012
    Publication date: January 3, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Stefan HENKE, Martin Andreas FOLGER, Jens SCHMALZ, Diana KEILHOFER, Hans-Juergen KROFF, Nina HERZ
  • HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS FOR NEEDLELESS INJECTION
    Publication number: 20080132493
    Abstract: Aqueous cyclodextrin-free solution of meloxicam suitable for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being from 35 to 100 mg/ml. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: August 27, 2007
    Publication date: June 5, 2008
    Inventors: Martin Andreas Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg
  • Water-soluble meloxicam granules
    Publication number: 20040180092
    Abstract: Water soluble meloxicam granules comprising:
    Type: Application
    Filed: October 27, 2003
    Publication date: September 16, 2004
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Stefan Henke, Martin Andreas Folger, Jens Schmalz, Diana Christine Keilhofer, Hans-Juergen Kroff, Nina Herz
  • Highly concentrated stable meloxicam solutions for needleless injection
    Publication number: 20030119825
    Abstract: Aqueous cyclodextrin-free solution of meloxicam suitable for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more suitable excipients, the content of dissolved meloxicam salt being from 35 to 100 mg/ml. The formulation according to the invention has a shelf-life of up to 24 months or more.
    Type: Application
    Filed: December 9, 2002
    Publication date: June 26, 2003
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Andreas Folger, Stefan Henke, Bernhard Hassel, Bernd Zierenberg